Background: Serum total bilirubin (TB) is a potent antioxidant and may be a negative risk factor of cardiovascular disease. In non-diabetic adults, hemoglobin A1c (HbA1c), but not fasting plasma glucose, is an independent risk factor of cardiovascular disease.
ilirubin is a potent antioxidant in the human body. 1 Increased serum levels of total bilirubin (TB) have been reported to be associated with reduced risk for cardiovascular disease (CVD) in some epidemiological studies and TB is suggested to be an independent risk factor for CVD. 2 Healthy subjects with lower TB levels have been found to have significant endothelial dysfunction and increased intima -media thickness (IMT) of the carotid artery, which are predictors for CVD. 3 TB has been suggested to be a novel risk marker of CVD in middle-aged men. 4 Increased TB is associated with reduced peripheral artery disease prevalence. 5 TB may have some protective function against stroke risk. 6 Low TB is associated with coronary artery calcification, which is a predictor of coronary artery events in Japanese people. 7 Gilbert syndrome, a genetic variant characterized by moderate hyperbilirubinemia, was reported to be associated with a reduced risk for CVD. 8 In subjects with Gilbert syndrome, elevated TB levels are associated with lower levels of advanced glycation endproducts that promote oxidant stress and inflammation. 9 Thus, TB may be a negative risk factor for CVD. In nondiabetic adults, however, fasting plasma glucose (FPG) was not significantly associated with risk of CVD and of death from any cause, adjusting for hemoglobin A1c (HbA1c). In contrast, HbA1c was significantly associated with risk of CVD and of death from any cause, adjusting for FPG. 10 HbA1c levels appear to increase with age 11 and will be influenced by any condition that changes red cell turnover, such as iron deficiency, hemolytic anemia, chronic malaria, major blood loss, or blood transfusions. 12 Other than age and hemoglobin metabolism, some cardiovascular risk factors may have an independent association with HbA1c. Thus, we hypothesized that the stronger association of HbA1c, than of FPG, with CVD, in nondiabetic adults may at least partly be mediated by the association between HbA1c and bilirubin in nondiabetic subjects. The aim of the present study was therefore to examine the cross-sectional association between TB and HbA1c in apparently healthy Japanese men and women who had no history of CVD and who were not on antidiabetic, antihypertensive, or antihyperlipidemic medication.
Measurements
After an overnight fast, blood samples were obtained to measure levels of HbA1c, FPG, triglycerides, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), high-sensitivity C-reactive protein (hs-CRP), and TB. Chemistry was assessed at BML Nagaoka (Nagaoka, Japan) using routine laboratory methods except for hs-CRP, which was measured at BML General Laboratory (Tokyo, Japan) with nephelometry using N-latex CRP-2 (Siemens Healthcare Japan, Tokyo, Japan). HbA1c was measured with a latex aggregation immunoassay using Determiner HbA1c (Kyowa Medex, Tokyo, Japan). This assay is not affected by the presence of bilirubin when conjugated bilirubin concentrations are <40 mg/dl. In Japan, HbA1c levels are expressed in Japan Diabetes Society (JDS) units, and HbA1c levels in National Glycohemoglobin Standardization Program (NGSP) units in the following equation: HbA1c NGSPunits% = 1.02 × HbA1c JDSunits% + 0.3. LDL-C was measured with a direct surfactant method using Choletest-LDL (Sekisui Medical, Tokyo, Japan). The measurement limit of hs-CRP was 0.02 mg/L, and any results under this measurement limit were taken as being 0.01 mg/L. Average systolic blood pressure (SBP) and diastolic blood pressure (DBP) were calculated from 2 measurements done while the subjects were seated after a 5-min rest. Body weight was measured with the subjects wearing light clothes provided by the Center and the weight of the clothing was subtracted from the measured body weight. Waist circumference (WC) was measured at the level of the umbilicus with the subject standing. Body mass index (BMI) was calculated as weight in kilograms divided by the square of height in meters.
Statistical Analysis
Pearson correlation coefficients between age, BMI, SBP, DBP, FPG, triglycerides, HDL-C, LDL-C, hs-CRP, TB, and HbA1c, and both TB and HbA1c were calculated separately in male smokers and nonsmokers, and women. Linear regressions with stepwise exclusion of independent variables with P>0.05, using TB as a dependent variable and age, BMI, SBP, FPG, triglycerides, HDL-C, LDL-C, hs-CRP, and HbA1c as initial independent variables; linear regressions with stepwise exclusion of independent variables with P>0.05, using HbA1c as a dependent variable and age, BMI, SBP, FPG, triglycerides, HDL-C, LDL-C, hs-CRP, and TB as initial independent variables; and logistic regressions with stepwise exclusion of independent variables with P>0.05, using the highest decile (≥5.4%) of HbA1c as a dependent variable and age, BMI, SBP, FPG, triglycerides, HDL-C, LDL-C, hs-CRP, TB, and smoking status as initial independent variables, were performed separately in the men, and women. Triglyceride and hs-CRP were transformed to logarithms before calculations because of skewed distributions. WC and DBP were excluded from the initial independent variables in multivariate analysis to avoid multicollinearity. Continuous variables were divided ODA E et al.
by 1 SD before multivariate analysis to standardize each value. Statistical analyses were performed using Dr SPSS2 (SPSS Japan, Tokyo, Japan).
Results
Baseline data are presented in Table 1 . TB was significantly lower and hs-CRP was significantly higher in the smokers than in nonsmokers among the men, and HbA1c was not significantly different between smokers and nonsmokers. The Pearson correlation coefficients between age, BMI, SBP, DBP, FPG, triglycerides, HDL-C, LDL-C, hs-CRP, TB, and HbA1c, and both TB and HbA1c are given in Table 2 . The Pearson correlation coefficients between TB and HbA1c in the men and women were all significant. The multivariate linear regressions using TB as a dependent variable are listed in Table 3 . HbA1c was independently negatively, and FPG and HDL-C were independently positively associated with TB in the men and women. The hs-CRP level was independently negatively associated with TB in the male nonsmokers and the women, but not in the male smokers. The multivariate linear regressions using HbA1c as a dependent variable are given in Table 4 . FPG, age, TB, SBP, and LDL-C were independently associated with HbA1c in the men, and the women. The multivariate logistic regressions using the highest decile (≥5.4%) of HbA1c as a dependent variable are listed in Table 5 . FPG, age, and TB were independently associated with the highest decile (≥5.4%) of HbA1c in the nonsmokers and the women, but TB was not significantly associated with Bilirubin, A1c, and CVD the highest decile of HbA1c in the smokers.
Discussion
In the present cross-sectional study, TB was independently negatively associated with HbA1c in multivariate linear regressions in both smoking and nonsmoking men and in women, and was also independently negatively associated with the highest decile (≥5.4%) of HbA1c in multivariate logistic regressions in the nonsmoking men and the women. The results were essentially the same when we excluded independent variables with P>0.1 instead of P>0.05 in regression analyses (Tables S1-S3 ). The results were also similar when we examined the associations of TB with the highest quartile of HbA1c instead of the highest decile of HbA1c (Table S4) . We did not analyze smoking status in women separately because they comprise only 6.6% of current smokers in Japan.
In men, the association between TB and HbA1c was weaker in smokers than in nonsmokers. This phenomenon may have resulted from the decrease in TB levels ( Table 1) because of the pro-oxidant, pro-inflammatory (hs-CRP, Table 1) , and pro-insulin-resistant 13,14 (triglycerides, HDL-C, Table 1 ) effects of smoking. The catabolism of heme by heme oxygenase generates carbon monoxide, free iron, and biliverdin, which is rapidly converted to bilirubin by ubiquitously expressed biliverdin reductase. Although oxidation of LDL-C is critical for atherosclerotic vascular changes, 15 bilirubin suppresses the oxidation of lipid more than α-tocopherol. 1 Bilirubin efficiently scavenges a wide range of physiological oxidants by electron donation. In this process it is often re-converted to biliverdin, but biliverdin reductase quickly regenerates bilirubin, thereby greatly boosting its antioxidant potential. Schwertner et al suggested that serum TB is an inverse and independent risk factor for CVD. 2 Healthy subjects with lower TB levels have significant endothelial dysfunction and increased IMT of carotid artery, which are predictors for CVD. 3 Troughton et al suggested that TB is a novel risk marker of CVD in middleaged men, with a U-shaped relationship observed between TB and CVD risk in the Prospective Epidemiological Study of Myocardial Infarction. 4 Increased TB level is associated with reduced peripheral artery disease prevalence in a study from the National Health and Nutrition Examination Survey 1999-2004. 5 Kimm et al suggested that TB might have some protective function against stroke risk in Korean men. 6 Low TB level is associated with coronary artery calcification in Japanese subjects. 7 Gilbert syndrome, a genetic variant characterized by moderate hyperbilirubinemia attributable to reduced hepatic expression of the UDP-glucuronosyltransferase, which conjugates bilirubin, has been associated with a reduced risk for CVD. 8 In patients with cyanotic congenital heart disease, carotid IMT, and hence atherosclerosis disease risk, was decreased, which might be partly because of higher TB levels. 16 Yesilova et al suggested that the chronic hyperbilirubinemia in Gilbert syndrome leads to a lag-phase prolongation in LDL oxidation and a decrease in LDL oxidation. 17 In subjects with Gilbert syndrome, elevated TB levels are associated with lower levels of advanced glycation endproducts. 9 Recent data suggested a direct relationship between urinary excretion of biopyrrins, a novel group of bilirubin oxidative metabolites, and severity of oxidative stress. Yamaguchi et al investigated the antioxidative effect of bilirubin in a rat liver model of ischemia -reperfusion and demonstrated that the hepatic mRNA level of heme oxygenase-1 (HO-1) , the rate-limiting enzyme of bilirubin biosynthesis, and the amount of biopyrrins in urine increased after ischemia -reperfusion injury. 18 They suggested that bilirubin acts as a physiological antioxidant in vivo in ischemiareperfusion and that bilirubin biosynthesis is evoked by oxidative stress. 18 Vítek et al demonstrated an inverse relationship between serum bilirubin level and urinary excretion of biopyrrins and suggested antioxidative effects of elevated serum bilirubin levels in Gilbert syndrome. 19 Yamamoto et al studied the dynamics of oxidative stress after myocardial ischemia reperfusion in rat models using urinary excretion of biopyrrins and their generation in various organs as oxidative stress markers and suggested that urinary excretion of biopyrrins can serve as a useful marker of systemic oxidative stress after myocardial ischemia -reperfusion. 20 Ueyama et al reported that cardiac and aortic macrophages upregulate HO-1 in response to emotional stress and catecholamine surges as an endogenous defense mechanism against oxidative stress in rat models of takotsubo cardiomyopathy. 21 Kunii et al demonstrated that serum bilirubin and biopyrrins were elevated in patients with acute myocardial infarction, and that biopyrrins and HO-1 expression were increased in the infarcted myocardium and that plasma and urinary biopyrrin elevation was associated with mortality and morbidity. 22 These data suggest the involvement of bilirubin/biopyrrin pathway in the pathophysiology of CVD. Inoguchi et al reported a lower prevalence of CVD in patients with diabetes and Gilbert syndrome, and suggested that sustained hyperbilirubinemia inhibits oxidative stress and prevents the development of CVD in diabetic patients. 23 HbA1c is a reliable marker of chronic glycemia and correlates well with the risk of long-term diabetes complications, 24 and is the test of choice for the chronic management of diabetes and is recommended for its diagnosis. 12 In the Atherosclerosis Risk in Communities (ARIC) study of non-diabetic adults, HbA1c was similarly associated with a risk of diabetes as FPG and was more strongly associated with risks of CVD ODA E et al.
and death from any cause than FPG. 10 FPG was not significantly associated with risks of CVD and death from any cause adjusting for HbA1c, whereas HbA1c was significantly associated with risks of CVD and death from any cause adjusting for FPG. 10 HbA1c levels appear to increase with age 11 and in iron deficiency. 25, 26 Other than age and iron deficiency, some cardiovascular risk factors may be independently associated with HbA1c. Ohnaka et al studied the association of TB with hs-CRP, HbA1c, and the prevalence of diabetes in middleaged and elderly Japanese men and women. 27 In their study, geometric means of hs-CRP and HbA1c were progressively lower with increasing levels of TB, and an inverse association between TB and HbA1c adjusted for age, BMI, smoking and other lifestyle-related confounding factors, and liver function tests was slightly attenuated after further adjustment for hs-CRP, but still remained significant. 27 They suggested that TB probably confers protection against the development of diabetes. 27 In the present study among apparently healthy Japanese men and women, TB was independently negatively associated with HbA1c in multivariate linear regressions adjusted for age, BMI, hs-CRP, and other cardiovascular risk factors in male smokers and nonsmokers, and was also independently negatively associated with the highest decile (≥5.4%) of HbA1c in the nonsmokers. Thus, TB, a potent antioxidant in vivo, was negatively associated with HbA1c adjusting for cardiovascular risk factors and so the stronger association of HbA1c, than of FPG, with CVD in nondiabetic subjects may at least partly be mediated by the inverse association between HbA1c and TB.
Study Limitations
The present study was a cross-sectional study and the subjects were not a general population but visitors to a medical check-up center that is in a central city of a rural region in Japan. Studies in larger populations and longitudinal studies are warranted to test the present conclusions.
Conclusions
Bilirubin was negatively associated with HbA1c independently of FPG, age, and other cardiovascular risk factors in apparently healthy Japanese men and women who had no history of CVD and who were not taking antidiabetic, antihypertensive, or antihyperlipidemic medication. The association was weak in male smokers. It suggests that the stronger association of HbA1c, than FPG, with CVD in nondiabetic subjects may at least partly be mediated by the inverse association between HbA1c and TB. 
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